Merck & Company (MRK)

$81.49 +2.18 (2.75%)
Market Cap 200.78B
Revenue (ttm) 64.17B
Net Income (ttm) 17.12B
EPS (ttm) N/A
PE Ratio 10.46
Forward PE 9.21
Profit Margin 26.68%
Debt to Equity Ratio 0.69
Volume 4,411,719
Avg Vol 15,678,630
Day's Range N/A - N/A
Shares Out 2.51B
Stochastic %K 6%
Beta 0.39
Analysts Strong Sell
Price Target $103.68

Company Profile

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 908 740 4000
Address:
126 East Lincoln Avenue, Rahway, United States
Jimmyboy29
Jimmyboy29 Jul. 22 at 4:44 PM
$BMY 🚨Unusual institutional activity detected in the last 15min. They bought a massive block of 10,000 of the $52.50 bristol myers calls for 11/22/25. This is very notable because they are taking this position into earnings in 9 days. Likely they are expecting this healthcare momentum to continue into and after earnings. 🔑$1.7m premium. $NVO $MRK $PFE $SPY
0 · Reply
Jimmyboy29
Jimmyboy29 Jul. 22 at 4:22 PM
$BMY $XLV $MRK $NVO $SPY beautiful call before the squeeze. Major rotation underway.
1 · Reply
SenefAS
SenefAS Jul. 22 at 2:27 PM
$MCRB $MRK $VRNA Eric step down for one reason if now the future and know it will be not part of the plan… ‘’Today it’s a good news :‘’Engagements with several parties are underway regarding various deal structures, including potential business development and partnership opportunities, aimed at securing additional capital and support for continued advancement of our pipeline. We are working with focus and urgency, leveraging our collective transaction and capital sourcing experiences, to enable the clinical progression of SER-155 and deliver value for patients and shareholders.”
0 · Reply
Fizzer
Fizzer Jul. 22 at 2:03 PM
$MRK added to my long position.
0 · Reply
ImBrokerage
ImBrokerage Jul. 22 at 1:52 PM
$MRK easy trade right at the bell!
0 · Reply
ImBrokerage
ImBrokerage Jul. 22 at 1:39 PM
$UNH $MRK $GRRR just made a lil morning portfolio 💼
0 · Reply
YoungRoddyMoon
YoungRoddyMoon Jul. 22 at 12:30 PM
$MRK trading at three year lows, FPE of about 8, dividend over 4% and room to grow.. what am i missing here?! Easy buy and hold for an undervalued stock in the most undervalued sector at the moment 🚀
0 · Reply
JElway
JElway Jul. 22 at 11:49 AM
$MRK https://finance.yahoo.com/news/merck-co-inc-mrk-breaks-223043176.html
0 · Reply
clan
clan Jul. 22 at 10:44 AM
$MNKD Imminent FDA pediatric approval for Afrezza is projected to be an "inflection point" in the histories of both: inhalable mealtime insulin ... and ... all of mannkind! 🚫💉 🤸‍♂️🏃👫 Follow the pros. $AMGN or $MRK might be of interest. 💎👐
1 · Reply
Pilot_Trader
Pilot_Trader Jul. 21 at 6:50 PM
$MRK added more
0 · Reply
Latest News on MRK
Merck Announces Fourth-Quarter 2025 Dividend

Jul 22, 2025, 11:53 AM EDT - 1 hour ago

Merck Announces Fourth-Quarter 2025 Dividend

Rapid Micro Biosystems: Benefiting From Partnership With Merck; Initiating With 'Buy'

Jul 22, 2025, 9:18 AM EDT - 3 hours ago

Rapid Micro Biosystems: Benefiting From Partnership With Merck; Initiating With 'Buy'

RPID

Merck Commits to Veeva Vault CRM

Jul 21, 2025, 10:00 AM EDT - 1 day ago

Merck Commits to Veeva Vault CRM

VEEV

July's 5 Dividend Growth Stocks With Yields Up To 7.96%

Jul 18, 2025, 2:46 PM EDT - 3 days ago

July's 5 Dividend Growth Stocks With Yields Up To 7.96%

ABBV APAM BLK BMY EBF NWE PFE

Livestock Identification Company Evaluation Report 2025 | Merck, Shearwell, Datamars Drive Innovations with Comprehensive Tagging and Tracking Solutions

Jul 18, 2025, 5:06 AM EDT - 4 days ago

Livestock Identification Company Evaluation Report 2025 | Merck, Shearwell, Datamars Drive Innovations with Comprehensive Tagging and Tracking Solutions

Merck & Co., Inc. (MRK) Presents at HIV Investor Event Transcript

Jul 17, 2025, 6:24 PM EDT - 4 days ago

Merck & Co., Inc. (MRK) Presents at HIV Investor Event Transcript

Why Merck Is A Better Dividend Stock Than Gilead Sciences

Jul 16, 2025, 3:08 PM EDT - 5 days ago

Why Merck Is A Better Dividend Stock Than Gilead Sciences

GILD

Amphista Therapeutics announces achievement of a research milestone in its collaboration with Merck triggering a milestone payment

Jul 16, 2025, 7:00 AM EDT - 6 days ago

Amphista Therapeutics announces achievement of a research milestone in its collaboration with Merck triggering a milestone payment

Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill

Jul 14, 2025, 9:31 AM EDT - 8 days ago

Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill

VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA

Jul 12, 2025, 9:09 PM EDT - 9 days ago

VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA

VRNA

Merck's Verona Acquisition: Plugging A $4B Hole In A $20B Gap

Jul 11, 2025, 7:10 AM EDT - 11 days ago

Merck's Verona Acquisition: Plugging A $4B Hole In A $20B Gap

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

Jul 10, 2025, 4:45 PM EDT - 11 days ago

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

U.S. FDA Accepts New Drug Application for Merck's Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection

Jul 10, 2025, 6:45 AM EDT - 12 days ago

U.S. FDA Accepts New Drug Application for Merck's Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection

Measuring Options Activity in MRK & XLV: Healthcare Levels to Watch

Jul 9, 2025, 4:00 PM EDT - 12 days ago

Measuring Options Activity in MRK & XLV: Healthcare Levels to Watch

XLV

Major deals involving U.S. drugmakers and biotechs over the past decade

Jul 9, 2025, 1:46 PM EDT - 12 days ago

Major deals involving U.S. drugmakers and biotechs over the past decade

VRNA

Undercovered Dozen: Roku, Merck, Chevron And More

Jul 9, 2025, 12:59 PM EDT - 13 days ago

Undercovered Dozen: Roku, Merck, Chevron And More

CVX ROKU

Merck to Buy Verona Pharma for Around $10 Billion

Jul 9, 2025, 12:36 PM EDT - 13 days ago

Merck to Buy Verona Pharma for Around $10 Billion

VRNA

Merck has struck a roughly $10 billion deal to buy Verona Pharma

Jul 9, 2025, 10:36 AM EDT - 13 days ago

Merck has struck a roughly $10 billion deal to buy Verona Pharma

VRNA

META Stake in Ray-Ban & Oakley Maker, MRK Acquiring VRNA, TMUS Downgrade

Jul 9, 2025, 10:30 AM EDT - 13 days ago

META Stake in Ray-Ban & Oakley Maker, MRK Acquiring VRNA, TMUS Downgrade

META TMUS

Merck to buy Verona for $10 billion ahead of Keytruda patent expiration

Jul 9, 2025, 9:23 AM EDT - 13 days ago

Merck to buy Verona for $10 billion ahead of Keytruda patent expiration

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug

Jul 9, 2025, 9:03 AM EDT - 13 days ago

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug

Merck dives into COPD treatments with $10 billion purchase of Verona Pharma

Jul 9, 2025, 7:48 AM EDT - 13 days ago

Merck dives into COPD treatments with $10 billion purchase of Verona Pharma

VRNA

Merck buys Verona for $10 billion

Jul 9, 2025, 7:47 AM EDT - 13 days ago

Merck buys Verona for $10 billion

Verona Pharma Stock Jumps 21%. It's Being Bought for $10 Billion by Merck.

Jul 9, 2025, 7:14 AM EDT - 13 days ago

Verona Pharma Stock Jumps 21%. It's Being Bought for $10 Billion by Merck.

VRNA

Merck to Buy Verona Pharma in $10 Billion Deal

Jul 9, 2025, 6:48 AM EDT - 13 days ago

Merck to Buy Verona Pharma in $10 Billion Deal

VRNA

Merck to acquire Verona Pharma for $10 billion

Jul 9, 2025, 6:39 AM EDT - 13 days ago

Merck to acquire Verona Pharma for $10 billion

VRNA

Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade

Jul 9, 2025, 6:30 AM EDT - 13 days ago

Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade

VRNA

Merck nears $10 billion deal for respiratory drugmaker Verona, FT reports

Jul 9, 2025, 1:09 AM EDT - 13 days ago

Merck nears $10 billion deal for respiratory drugmaker Verona, FT reports

VRNA

Merck to Present New Data Highlighting Research Advancements Across its HIV Prevention and Treatment Pipeline at IAS 2025

Jul 8, 2025, 6:45 AM EDT - 14 days ago

Merck to Present New Data Highlighting Research Advancements Across its HIV Prevention and Treatment Pipeline at IAS 2025

My Top 10 High-Yield Dividend Stocks For July 2025: One Yields 12%-Plus

Jul 7, 2025, 6:00 PM EDT - 14 days ago

My Top 10 High-Yield Dividend Stocks For July 2025: One Yields 12%-Plus

ARCC BTI CVX MO PEP PFE PM

Merck & Co.: A Pharma Titan At A Discount

Jul 7, 2025, 12:48 PM EDT - 15 days ago

Merck & Co.: A Pharma Titan At A Discount

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (July 2025)

Jul 5, 2025, 8:00 AM EDT - 17 days ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (July 2025)

ADP AES AMH APH ARCC ASR AVGO

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Jul 3, 2025, 8:03 AM EDT - 19 days ago

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

CVS PFE

FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial

Jul 2, 2025, 6:45 AM EDT - 20 days ago

FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial

Top 15 High-Growth Dividend Stocks For July 2025

Jul 1, 2025, 9:02 PM EDT - 20 days ago

Top 15 High-Growth Dividend Stocks For July 2025

APH BAC BK DKS DPZ ELV GPN

Top 10 High-Yield Dividend Stocks For July 2025

Jul 1, 2025, 2:06 PM EDT - 20 days ago

Top 10 High-Yield Dividend Stocks For July 2025

AVGO BK CMCSA CRH EOG GS INTC

Dividend Yield Theory Says Merck Is A Buy

Jul 1, 2025, 1:57 PM EDT - 20 days ago

Dividend Yield Theory Says Merck Is A Buy

Merck Foundation Chairman, CEO, and 14 First Ladies Inaugurate the 7th Edition of Merck Foundation First Ladies Initiative - MFFLI Summit in Dubai

Jul 1, 2025, 8:49 AM EDT - 21 days ago

Merck Foundation Chairman, CEO, and 14 First Ladies Inaugurate the 7th Edition of Merck Foundation First Ladies Initiative - MFFLI Summit in Dubai

Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29

Jul 1, 2025, 6:45 AM EDT - 21 days ago

Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29

Merck: Don't Let Today's Bargain Opportunity Pass You By

Jun 29, 2025, 3:38 AM EDT - 23 days ago

Merck: Don't Let Today's Bargain Opportunity Pass You By

Merck: Cheap Stock, But Still Relying Heavily On Keytruda (Rating Upgrade)

Jun 27, 2025, 1:36 PM EDT - 24 days ago

Merck: Cheap Stock, But Still Relying Heavily On Keytruda (Rating Upgrade)

40% Upside For Merck Stock?

Jun 27, 2025, 7:05 AM EDT - 25 days ago

40% Upside For Merck Stock?

Merck's RSV shot for infants gets key approval despite RFK Jr.'s panel shakeup

Jun 26, 2025, 3:47 PM EDT - 25 days ago

Merck's RSV shot for infants gets key approval despite RFK Jr.'s panel shakeup

ACIP Recommends Use of Merck's ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season

Jun 26, 2025, 1:39 PM EDT - 25 days ago

ACIP Recommends Use of Merck's ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season

New vaccine panel meeting underway

Jun 26, 2025, 11:46 AM EDT - 26 days ago

New vaccine panel meeting underway

BDX BMY UNH ZBH

RFK Jr.'s CDC vaccine panel backs Merck RSV shot for infants

Jun 26, 2025, 10:03 AM EDT - 26 days ago

RFK Jr.'s CDC vaccine panel backs Merck RSV shot for infants

ACIP recommends Merck's RSV shot for infants under 8 months old

Jun 26, 2025, 9:34 AM EDT - 26 days ago

ACIP recommends Merck's RSV shot for infants under 8 months old

US CDC panel votes in favor of Merck's RSV antibody drug

Jun 26, 2025, 9:00 AM EDT - 26 days ago

US CDC panel votes in favor of Merck's RSV antibody drug

Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention

Jun 24, 2025, 6:45 AM EDT - 4 weeks ago

Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention

Jimmyboy29
Jimmyboy29 Jul. 22 at 4:44 PM
$BMY 🚨Unusual institutional activity detected in the last 15min. They bought a massive block of 10,000 of the $52.50 bristol myers calls for 11/22/25. This is very notable because they are taking this position into earnings in 9 days. Likely they are expecting this healthcare momentum to continue into and after earnings. 🔑$1.7m premium. $NVO $MRK $PFE $SPY
0 · Reply
Jimmyboy29
Jimmyboy29 Jul. 22 at 4:22 PM
$BMY $XLV $MRK $NVO $SPY beautiful call before the squeeze. Major rotation underway.
1 · Reply
SenefAS
SenefAS Jul. 22 at 2:27 PM
$MCRB $MRK $VRNA Eric step down for one reason if now the future and know it will be not part of the plan… ‘’Today it’s a good news :‘’Engagements with several parties are underway regarding various deal structures, including potential business development and partnership opportunities, aimed at securing additional capital and support for continued advancement of our pipeline. We are working with focus and urgency, leveraging our collective transaction and capital sourcing experiences, to enable the clinical progression of SER-155 and deliver value for patients and shareholders.”
0 · Reply
Fizzer
Fizzer Jul. 22 at 2:03 PM
$MRK added to my long position.
0 · Reply
ImBrokerage
ImBrokerage Jul. 22 at 1:52 PM
$MRK easy trade right at the bell!
0 · Reply
ImBrokerage
ImBrokerage Jul. 22 at 1:39 PM
$UNH $MRK $GRRR just made a lil morning portfolio 💼
0 · Reply
YoungRoddyMoon
YoungRoddyMoon Jul. 22 at 12:30 PM
$MRK trading at three year lows, FPE of about 8, dividend over 4% and room to grow.. what am i missing here?! Easy buy and hold for an undervalued stock in the most undervalued sector at the moment 🚀
0 · Reply
JElway
JElway Jul. 22 at 11:49 AM
$MRK https://finance.yahoo.com/news/merck-co-inc-mrk-breaks-223043176.html
0 · Reply
clan
clan Jul. 22 at 10:44 AM
$MNKD Imminent FDA pediatric approval for Afrezza is projected to be an "inflection point" in the histories of both: inhalable mealtime insulin ... and ... all of mannkind! 🚫💉 🤸‍♂️🏃👫 Follow the pros. $AMGN or $MRK might be of interest. 💎👐
1 · Reply
Pilot_Trader
Pilot_Trader Jul. 21 at 6:50 PM
$MRK added more
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 21 at 6:42 PM
Merck Commits To Veeva’s Vault CRM, Draws Wall Street Cheer: Retail’s Not Enthusiastic $VEEV $MRK https://stocktwits.com/news/equity/markets/merck-commits-to-veeva-vault-crm-draws-wall-street-cheer/ch8AkQ6R5rM
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Jul. 21 at 6:23 PM
$MRK held above that 50dma on Daily chart and trying to play into a position here today
0 · Reply
Jimmyboy29
Jimmyboy29 Jul. 21 at 5:58 PM
$BMY violent reversal set up in my opinion. There is alot of momentum and rotation under the surface in healthcare. Lots of call buying in the $XLV Like $MRK & $NVO for a swing here also. $SPY
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 21 at 4:19 PM
Merck’s Blockbuster Drug Keytruda Gets Canadian Regulator’s Approval For Treating Cervical Cancer: Retail Investors Appear Divided $MRK $PPH $PJP https://stocktwits.com/news/equity/markets/merck-blockbuster-drug-keytruda-gets-canadian-regulator-approval-for-treating-cervical-cancer/ch8AilFR5rS
0 · Reply
spacoli
spacoli Jul. 21 at 4:07 PM
$MRK jumped in with 500 shares at 79.30
0 · Reply
Stonehere
Stonehere Jul. 21 at 4:06 PM
$MRK a technical bounce at this level seems fair
0 · Reply
Bigplayer23
Bigplayer23 Jul. 21 at 3:13 PM
$LEXX $NVO $LLY $MRK $PFE Hit it
0 · Reply
MHM7700
MHM7700 Jul. 21 at 2:48 PM
45% gains locked in on the $MRK puts. scaled out of half position. holding rest half with s/l @ +5%. no matter what, this is a green trade for us now. https://stocktwits.com/MHM7700/message/621550286
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Jul. 21 at 2:12 PM
$MRK Dead $$ move on All biotech and medical device are dead
0 · Reply
Makingmillions192
Makingmillions192 Jul. 21 at 1:42 PM
$LEXX $LLY $MRK $NVO
0 · Reply
Bigplayer23
Bigplayer23 Jul. 21 at 1:30 PM
$LEXX $NVO $LLY $MRK $LEXX institutional investors being big spenders, big volume, test results coming soon among others things points to Big things coming!
0 · Reply
Gaspacman
Gaspacman Jul. 21 at 12:39 PM
$NCNA $MRK hang on we gonna rocket on successful partnership ✅
1 · Reply